China Feihe Limited (HKG:6186)

Market Cap	26.78B -51.6%
Revenue (ttm)	20.16B -12.7%
Net Income	2.16B -45.7%
EPS	0.23 -46.2%
Shares Out	8.81B
PE Ratio	13.01
Forward PE	9.75
Dividend	0.25 (8.17%)
Ex-Dividend Date	Jun 9, 2026

Volume	17,928,000
Open	3.030
Previous Close	3.040
Day's Range	2.980 - 3.040
52-Week Range	2.990 - 6.050
Beta	0.53
Analysts	Buy
Price Target	4.44 (+47.51%)
Earnings Date	Aug 28, 2026

About China Feihe

China Feihe Limited, an investment holding company, produces and sells dairy products, raw milk, and nutritional supplements in Mainland China, Canada, Indonesia, and the United States. It operates through two segments, Dairy Products and Nutritional Supplements Products; and Raw Milk. The company offers dairy products adult milk powders; liquid milk products; and rice powder supplement products, as well as health care products. It also retails vitamins, minerals, herbs, and other nutritional supplements. The company sells its products distribu...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1962
• Employees: 9,480
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 6186

Financial Performance

In 2025, China Feihe's revenue was 18.11 billion, a decrease of -12.70% compared to the previous year's 20.75 billion. Earnings were 1.94 billion, a decrease of -45.68%.

Financial numbers in CNY

Analyst Summary

According to 16 analysts, the average rating for 6186 stock is "Buy." The 12-month stock price target is $4.44, which is an increase of 47.51% from the latest price.

Price Target

$4.44

(47.51% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 18, 2026

Data Sources Report a data error